Board Meetings for NEULANDLAB
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| NEULANDLAB | Neuland Laboratories Limited | 01 Aug 2024 | NEULAND LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 01-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . | Board Meeting Intimation | |
| NEULANDLAB | Neuland Laboratories Limited | 10 May 2024 | NEULAND LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 10-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. | Board Meeting Intimation | |
| NEULANDLAB | Neuland Laboratories Limited | 10 May 2024 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend | |
| NEULANDLAB | Neuland Laboratories Limited | 08 Feb 2024 | NEULAND LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 08-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . | Board Meeting Intimation | |
| NEULANDLAB | Neuland Laboratories Limited | 08 Feb 2024 | Financial Results | To consider and approve the unaudited Financial Results of the Company for the Quarter and nine months ended December 31, 2023 | |
| NEULANDLAB | Neuland Laboratories Limited | 07 Nov 2023 | NEULAND LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 . | Board Meeting Intimation | |
| NEULANDLAB | Neuland Laboratories Limited | 07 Nov 2023 | Financial Results | To consider and approve the financial results for the period ended September 30, 2023 | |
| NEULANDLAB | Neuland Laboratories Limited | 03 Aug 2023 | NEULAND LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 03-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 . | Board Meeting Intimation | |
| NEULANDLAB | Neuland Laboratories Limited | 03 Aug 2023 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 | |
| NEULANDLAB | Neuland Laboratories Limited | 11 May 2023 | NEULAND LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 11-May-2023 to consider financial statements for the period ended March 2023, Financial results/Dividend. | Board Meeting Intimation | |
| NEULANDLAB | Neuland Laboratories Limited | 11 May 2023 | Financial Results/Dividend | Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 11, 2023, inter-alia to a) consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2023, and; b) recommend final dividend, if any, for the financial year ended March 31, 2023 | |
| NEULANDLAB | Neuland Laboratories Limited | 13 Feb 2023 | Financial Results | To consider and approve the unaudited Financial Results for the quarter and nine months ended December 31, 2022 | |
| NEULANDLAB | Neuland Laboratories Limited | 10 Nov 2022 | Financial results | Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022 | |
| NEULANDLAB | Neuland Laboratories Limited | 03 Aug 2022 | Financial results | Neuland Laboratories Limited has informed the Exchange about Board Meeting to be held on 03-Aug-2022 to consider financial statements for the period ended June 2022 | |
| NEULANDLAB | Neuland Laboratories Limited | 10 May 2022 | Dividend/Financial results/Other business matters | Neuland Laboratories Limited has informed the Exchange about Board Meeting to be held on 10-May-2022 to consider Audited financial Results for the Financial year ended March 31, 2022, final dividend for FY FY 2021-22 and Other business matters |